ArticleInternational journal of clinical and experimental pathology2017
Bcl-xL expression improves the therapeutic effect of human umbilical cord stem cell transplantation on articular cartilage injury in rabbit.
Article in International journal of clinical and experimental pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
- Bcl-xL expression following articular cartilage injury and its effects on the biological function of chondrocytes.Engineering in life sciences · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo investigate the therapeutic effect of transplantation of B-cell lymphoma-extra large (Bcl-xL) gene modified human umbilical cord blood stem cells (HUCSCs) on rabbit articular cartilage injury. MATERIALS AND
methodsHUCSCs were isolated and identified. Lentiviral encoding Bcl-xL was applied to modify HUCSCs. The effects of Bcl-xL overexpression on apoptosis and related gene expression after differentiation induction of HUCSCs were detected. Additionally, the efficiency of transplantation of Bcl-xL gene modified HUCSCs on articular cartilage injury were evaluated.
resultsHUCSCs could differentiate into chondrocytes after induction. Compared with control group, the apoptosis after induction was significantly elevated, but reduced by Bcl-xL gene overexpression. The differentiation of HUCSCs into chondrocytes was displayed by expression of type II collagen (CII), but accompanying with expression of caspase-3 and matrix metalloproteinase-3 (MMP-3). By contrast, Bcl-xL gene overexpression reduced caspase-3 and MMP-3 expression, but further increased CII expression. Pathological staining showed that Bcl-xL gene modified HUCSCs could obviously repair cartilage injury. Compared with sham control group, the expression of caspase-3 and MMP-3 in model group was significantly up-regulated, while the expression of CII was significantly down-regulated. Transplantation of HUCSCs could ameliorate the injury, while Bcl-xL modification could improve the therapeutic effect of transplantation of HUCSCs. Moreover, Bcl-xL modification could further decrease cartilage injury-induced expression of caspase-3 and MMP-3, and improve the expression of CII compared with transplantation of normal HUCSCs.
conclusionsBcl-xL gene modification decreases cell differentiation-induced apoptosis and improves the efficiency of HUCSCs transplantation in the repairing of cartilage injury.
Indexed as
Identifiers
31966417PMC6965849W3027238157What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.